Your browser doesn't support javascript.
loading
Network pharmacology- and molecular simulation-based exploration of therapeutic targets and mechanisms of heparin for the treatment of sepsis/COVID-19.
Fang, Yitian; Lin, Shenggeng; Dou, Qingli; Gui, Jianjun; Li, Weimin; Tan, Hongsheng; Wang, Yanjing; Zeng, Jumei; Khan, Abbas; Wei, Dong-Qing.
Affiliation
  • Fang Y; State Key Laboratory of Microbial Metabolism, Shanghai-Islamabad-Belgrade Joint Innovation Center on Antibacterial Resistances, Joint International Laboratory on Metabolic & Developmental Sciences, School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
  • Lin S; Peng Cheng Laboratory, Shenzhen, Guangdong, China.
  • Dou Q; State Key Laboratory of Microbial Metabolism, Shanghai-Islamabad-Belgrade Joint Innovation Center on Antibacterial Resistances, Joint International Laboratory on Metabolic & Developmental Sciences, School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
  • Gui J; Department of Emergency Medicine, Affiliated Baoan Hospital of Shenzhen, Southern Medical University, Shenzhen, Guangdong, China.
  • Li W; Department of Emergency Medicine, Affiliated Baoan Hospital of Shenzhen, Southern Medical University, Shenzhen, Guangdong, China.
  • Tan H; National Tuberculosis Clinical Lab of China, Beijing Chest Hospital, Capital Medical University, Beijing, China.
  • Wang Y; Clinical Research Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zeng J; Engineering Research Center of Cell and Therapeutics Antibody, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.
  • Khan A; West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Wei DQ; State Key Laboratory of Microbial Metabolism, Shanghai-Islamabad-Belgrade Joint Innovation Center on Antibacterial Resistances, Joint International Laboratory on Metabolic & Developmental Sciences, School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
J Biomol Struct Dyn ; 41(22): 12586-12598, 2023.
Article in En | MEDLINE | ID: mdl-36661370
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drugs, Chinese Herbal / Sepsis / COVID-19 Limits: Humans Language: En Journal: J Biomol Struct Dyn Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drugs, Chinese Herbal / Sepsis / COVID-19 Limits: Humans Language: En Journal: J Biomol Struct Dyn Year: 2023 Document type: Article Affiliation country: Country of publication: